Dr. Kyle Farh is Vice President at Illumina’s Artificial Intelligence (AI) Lab for Genome Interpretation, where he works on deciphering the clinical impact of genetic variants in rare and common diseases. Towards this goal, Kyle leads a multidisciplinary research team of deep learning scientists, statistical geneticists, and molecular biologists. Prior to joining Illumina, Kyle was an attending physician at Boston Children’s Hospital. Kyle completed his postdoc fellowship in Medical and Population Genetics at the Broad Institute, and received his PhD in Molecular Biology at MIT, and MD at Harvard Medical School.

‍